Watson began selling Quasense, its version of Seasonale, 15 months ago. Sandoz is seeking US Food and Drug Administration permission to sell a copy. ...
The lawsuit asserts that Watson's Quasense product infringes Duramed's US patent number 5895032. Watson launched its Quasense product in September 2006 ...
In September 2006, Watson launched Quasense, a generic version of Seasonale, after final approval from the US Food & Drug Administration, according to Barr. ...
all 10 news articles
Watson launched its Quasense(TM) product in September 2006 following the US Food and Drug Administration''s final approval of its abbreviated new drug ...
The lawsuit affirmed that Watson's Quasense product infringed Duramed's US Patent. The Corona, California-based company's President and Chief Executive ...
Watson began selling its generic version of Seasonale under the Quasense brand name in September of 2006. Novartis' generic unit, Sandoz, last month filed ...
The lawsuit asserts that Watson's Quasense infringes a Duramed US patent. Watson launched its Quasense product in September 2006, the company noted. ...
The lawsuit alleges that Watson's Quasense product infringes Duramed's patent related to Seasonale. Watson launched its Quasense product in September 2006 ...
The lawsuit asserts that Watson's Quasense(TM) product infringes Duramed's US Patent 5895032 ('032). "We fully intend to continue to market Quasense(TM), ...